RGNX
REGENXBIO Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.92
−3.04%Leverage
- Debt / equity
- 0.96x
- Net debt / equity
- 0.45x
- Debt / assets
- 0.18x
- Debt / EBITDA
- -0.50x
- Net debt / EBITDA
- -0.23x
Liquidity & coverage
- Current ratio
- 2.86x
- Quick ratio
- 2.86x
- Cash ratio
- 1.28x
- Interest coverage
- -3.91x
- EBITDA / interest
- -3.32x
- Working capital
- $153.5M
Cash & dividend
- FCF / debt
- -3.62x
- Cash flow / debt
- -3.58x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026